🇺🇸 LGND — Ligand Pharmaceuticals Incorporated

Salud Compra fuerte
← Volver

Precio actual

307,02 USD

Máx. histórico

322,75

3 días

Split 1603:1000 del 02/11/2022

Caída desde máximo

-4,87%

Rango 52 semanas

175,89 – 326,63

Variación hoy

-4,87%

Cierre anterior

322,75

Rango de hoy

306,17 – 324,95

Volumen hoy

265.433

Peor caída histórica

-93,34%

06/03/2000 → 19/11/2008

Recuperado en 2694 días

Volatilidad anualizada ⓘ

59,76%

Información
Nombre completo
Ligand Pharmaceuticals Incorporated
Divisa
USD
Mercado
NasdaqGM
Sector
Salud
Industria
Biotechnology
Empleados
47
PER ⓘ
32,35 (puede no estar actualizado)
Dividend yield
0,00% (puede no estar actualizado)
Precio objetivo analistas
350,92 USD (puede no estar actualizado)
Primera cotización
18/11/1992
Precio actualizado
hace 1 día
Sobre la empresa

Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, develops and licenses biopharmaceutical assets worldwide. It offers Pradefovir, Posaconazole, Voriconazole, CAPVAXIVE, NOXAFIL, MenFive, and ZELSUVMI for infectious disease; EVOMELA and KYPROLIS for multiple myeloma; FILSPARI for the treatment of immunoglobulin a nephropathy; PNEUMOSIL, a pneumococcal conjugate vaccine to help fight against pneumococcal pneumonia in children; and QARZIBA to treat neuroblastoma. The company also provides Teriparatide injection product for osteoporosis; RYLAZE, a recombinant erwinia asparaginase for acute lymphoblastic leukemia or lymphoblastic lymphoma in adult and pediatric patients; TZIELD, a CD3-directed antibody indicated to delay the onset of Stage 3 type 1 diabetes in adults and children aged 8 years and older with Stage 2 T1D; and VAXNEUVANCE for the prevention of invasive disease caused by streptococcus pneumoniae serotypes. In addition, it offers Duavee for menopause; Frovatriptan to treat Neurology; FYCOMPA and SESQUIENT for CNS; MEKINIST for cardiology; Nexterone, a captisol-enabled formulation of amiodarone; VEKLURY, an antiviral treatment for COVID-19; and Viviant for osteoporosis. Further, the company develops ACLX-002, Ciforadenant, UGN-301, Viright, MB07133, BOT/BAL, and Lasofoxifene for oncology; Ensifentrine for respiratory disease; QTORIN for rare disease; Sparsentan for kidney disease; VK2809 for hepatology; ANEB-001 for acute cannabinoid intoxication; Reproxalap for opthamology; VK0214 for Rare Disease; and VK5211 for musculoskeletal disorder. The company was incorporated in 1987 and is based in Jupiter, Florida.

Dividendos repartidos Total últimos 12 meses: 0,0000 USD · Yield: 0,00%
Fecha de pago Importe por participación
03/04/2007 9,3575 USD
Splits Registrados en el histórico de precios
Fecha Ratio
02/11/2022 1603:1000
19/11/2010 1:6
Rentabilidad mensual
Evolución
Histórico día a día
Fecha Apertura Máximo Mínimo Cierre Variación Volatilidad día Volumen
14/09/1993 35,56 39,30 35,56 39,30 +10,53% 10,53% 1.095
13/09/1993 35,56 35,56 35,56 35,56 +0,00% 0,00% 347
10/09/1993 39,30 39,30 35,56 35,56 -9,52% 9,52% 427
09/09/1993 35,56 39,30 35,56 39,30 +0,00% 10,53% 2.244
08/09/1993 35,56 39,30 35,56 39,30 +7,69% 10,53% 267
07/09/1993 39,30 39,30 36,49 36,49 -4,88% 7,14% 534
03/09/1993 36,03 39,30 35,56 38,37 +3,80% 10,39% 4.515
02/09/1993 39,30 39,30 35,56 36,96 +1,28% 9,52% 1.389
01/09/1993 39,30 39,30 35,56 36,49 +2,63% 9,52% 748
31/08/1993 35,56 39,30 35,56 35,56 -9,52% 10,53% 3.927
30/08/1993 36,96 39,30 35,56 39,30 +10,53% 10,13% 561
27/08/1993 35,56 35,56 35,56 35,56 -7,32% 0,00% 347
26/08/1993 35,56 38,37 35,56 38,37 +7,89% 7,89% 802
25/08/1993 35,56 35,56 35,56 35,56 +0,00% 0,00% 53
24/08/1993 35,56 35,56 35,56 35,56 -7,32% 0,00% 160
23/08/1993 35,56 38,37 35,56 38,37 +7,89% 7,89% 5.611
20/08/1993 35,56 35,56 35,56 35,56 -3,80% 0,00% 534
19/08/1993 35,56 37,43 35,56 36,96 -1,25% 5,26% 11.755
18/08/1993 37,43 37,43 35,56 37,43 +5,26% 5,00% 14.374
17/08/1993 37,43 37,43 35,56 35,56 -7,32% 5,00% 1.363
16/08/1993 38,37 38,37 38,37 38,37 +7,89% 0,00% 1.603
13/08/1993 38,37 38,37 35,56 35,56 -1,30% 7,32% 160
12/08/1993 35,56 38,37 35,56 36,03 -6,10% 7,89% 1.496
11/08/1993 36,49 38,37 35,56 38,37 +5,13% 7,69% 508
10/08/1993 37,43 38,37 36,03 36,49 -2,50% 6,25% 1.149
09/08/1993 36,49 38,37 36,49 37,43 +2,56% 5,13% 962
06/08/1993 39,30 39,30 36,49 36,49 +0,00% 7,14% 668
05/08/1993 39,30 39,30 36,49 36,49 +0,00% 7,14% 695
04/08/1993 36,49 36,49 36,49 36,49 +0,00% 0,00% 107
03/08/1993 36,49 36,96 36,49 36,49 +0,00% 1,28% 294